Eddie Lau

The use of prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA PET/ CT) to guide stereotactic ablative body radiotherapy (SABR) for recurrent oligometastatic prostate cancer

Michael Chao, Wee Loon Ong, Daryl Lim Joon, Briana Farrugia, Eddie Lau, Vincent Khoo, Nathan Lawrentschuk, Damien Bolton, Tze Lui Koh, Farshad Foroudi

Conference Proceedings  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report

Ashray Gunjur, Geoff Chong, Adeline Lim, Eddie Lau, Paul Mitchell, Thomas John, Surein Arulananda

Journal article  |  2020  |  Clinical Lung Cancer

PRELIMINARY FINDINGS OF A PHASE I SAFETY AND BIOIMAGING TRIAL OF KB004 (IFABOTUZUMAB) IN PATIENTS WITH GLIOBLASTOMA

Hui Gan, Lawrence Cher, Po Inglis, Zarnie Lwin, Eddie Lau, Uwe Ackermann, Nicole Coombs, Kirsten Remen, Nancy Guo, Sze Ting Lee, Sylvia Gong, Jodie Palmer, Kunthi Pathmaraj, Graeme O'Keefe, Fiona Scott, Bryan Day, Andrew Boyd, Paul Thomas, Cameron Durrant, Andrew Scott

Conference Proceedings  |  2019  |  NEURO-ONCOLOGY

Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature

Wee Loon Ong, Tze Lui Koh, Daryl Lim Joon, Michael Chao, Briana Farrugia, Eddie Lau, Vincent Khoo, Nathan Lawrentschuk, Damien Bolton, Farshad Foroudi

Journal article  |  2019  |  BJU International

Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study

Pierre-Yves Le Roux, Amir Iravani, Jason Callahan, Kate Burbury, Peter Eu, Daniel P Steinfort, Eddie Lau, Beverly Woon, Pierre-Yves Salaun, Rodney J Hicks, Michael S Hofman

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging

Preliminary findings of a Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma

Hui Gan, Lawrence Cher, Po Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Uwe Ackermann, Nicole Coombs, Kirsten Remen, Nancy Guo, Sze Ting Lee, Sylvia Gong, Jodie B Palmer, Kunthi Pathmaraj, Graeme O'Keefe, Fiona Scott, Bryan W Day, Andrew W Boyd, Paul Thomas, Cameron Durrant, et al.

Conference Proceedings  |  2019  |  Clinical Trials

Independent and incremental value of Ventilation/Perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study

Pierre Yves Le Roux, Amir Iravani, Jason Callahan, Kate Burbury, Peter Eu, Daniel Steinfort, Eddie Lau, Pierre Salaun, Rodney Hicks, Michael Hofman

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease

Surein Arulananda, Hongdo Do, Gareth Rivalland, Zoe Loh, Ashan Musafer, Eddie Lau, Paul Mitchell, Alexander Dobrovic, Thomas John

Journal article  |  2019  |  Journal of Thoracic Disease

Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant

Numan Kutaiba, Zaid Ardalan, Kurvi Patwala, Eddie Lau, Mark Goodwin, Paul Gow

Journal article  |  2018  |  Transplantation Direct

TUMOR VOLUME AS A PREDICTOR OF RESPONSE TO ANTI-EGFR ADC ABT-414

Hui Gan, Aidan Seow, Eddie Lau, Lee Sze-Ting, Malaka Ameratunga, Yuliya Perchyonok, Diana Cao, Angela Rigopoulos, Ho-Jin Lee, Erica Gomez, David Maag, Andrew Scott

Conference Proceedings  |  2018  |  NEURO-ONCOLOGY